T/HBIQA 0007-2024 Active Group standards

T/HBIQA 0007-2024 Determination of six immunosuppressive drugs in human blood using high-performance liquid chromatography-tandem mass spectrometry

T/HBIQA 0007-2024 Determination of six immunosuppressive drugs in human blood using high-performance liquid chromatography-tandem mass spectrometry

Publish Date: 2024-08-15 Implement Date: 2024-10-15 For services related to genuine standard inquiry, procurement, translation, and other related services in China, please Contact Us
Price: $ 20.00
Out of stock

Basic Information

Standard Code: T/HBIQA 0007-2024
Standard Type: Group standards
Standard Status: Active
is_force_gb: no
CCS Name: -
ICS Name: Laboratory medicine
Publish Date: 2024-08-15
Implement Date: 2024-10-15

Scope

Main technical content: This document specifies a high-performance liquid chromatography-tandem mass spectrometry method for the detection of the content of six immunosuppressive drugs in human blood. This document is applicable to the determination of the content of mycophenolic acid, mycophenolate mofetil, tacrolimus, rapamycin, everolimus, and pimecrolimus in human blood.

Development Information

Related Standards

Contact Us